AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3778815 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural method of habit reversal combined with hydrocortisone cream
Number of subjects: 17
Study 3778815 — intervention group
Group type: COMPARATOR
Intervention: Regular ointment treatment (hydrocortisone cream alone)
Number of subjects: 17
Study 30081859 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg per night of capsulated sustained-release melatonin (Circadin)
Number of subjects: 34
Study 30081859 — intervention group
Group type: COMPARATOR
Intervention: 1 placebo capsule
Number of subjects: 34
Study 30081859 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline (no treatment)
Number of subjects: 34
Study 27274009 — intervention group
Group type: EXPERIMENTAL
Intervention: Pradigastat (115 mg intravenously)
Number of subjects: 0
Study 27274009 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg oral, positive control)
Number of subjects: 0
Study 27274009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25738335 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical interface (CI; OsseoSpeed, Dentsply Implants), n = 4
Number of subjects: 141
Study 25738335 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat-to-flat interface (FI; NobelSpeedy Replace, Nobel Biocare), n = 4
Number of subjects: 141
Study 25738335 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform-switch interface (PS; NanoTite Certain Prevail, Biomet 3i), n = 4
Number of subjects: 141
Study 22531616 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined rugby conditioning plyometric program (4 weeks)
Number of subjects: 35
Study 22531616 — intervention group
Group type: COMPARATOR
Intervention: Nonplyometric rugby conditioning program (control group)
Number of subjects: 35
Study 21840915 — intervention group
Group type: EXPERIMENTAL
Intervention: telephone cognitive behavioural therapy emphasizing physical activity
Number of subjects: 0
Study 21840915 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 0
Study 19842352 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment consisting of stretching, posture training, and auricular acupuncture
Number of subjects: 24
Study 19842352 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 24
Study 17101889 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced counseling and support intervention
Number of subjects: 406
Study 17101889 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 406
Study 15231974 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-treatment group (M&T performed promptly)
Number of subjects: 429
Study 15231974 — intervention group
Group type: EXPERIMENTAL
Intervention: Late-treatment group (M&T performed after a defined extended period)
Number of subjects: 429
Study 15231974 — intervention group
Group type: COMPARATOR
Intervention: Nontrial group (no M&T)
Number of subjects: 429
Study 11409520 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 U of heparin
Number of subjects: 103
Study 11409520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 9408302 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 42
Study 9408302 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 42
Study 8591483 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized phone follow-up
Number of subjects: 0
Study 8591483 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved access to medication
Number of subjects: 0
Study 8591483 — intervention group
Group type: EXPERIMENTAL
Intervention: One-on-one follow-up conversations concerning compliance issues
Number of subjects: 0
Study 2475710 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (2.5, 5, and 7.5 mg b.i.d. every 3rd week)
Number of subjects: 20
Study 1021720 — intervention group
Group type: EXPERIMENTAL
Intervention: Althesin
Number of subjects: 40
Study 1021720 — intervention group
Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 40
Study 31148210 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral dextrose infusion for 24 hours (n=30)
Number of subjects: 60
Study 31148210 — intervention group
Group type: COMPARATOR
Intervention: Water (placebo) infusion for 24 hours (n=30)
Number of subjects: 60
Study 31062050 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical power normalized to predicted body weight (norMP)
Number of subjects: 5159
Study 31062050 — intervention group
Group type: COMPARATOR
Intervention: Absolute mechanical power (MP)
Number of subjects: 5159
Study 31062050 — intervention group
Group type: COMPARATOR
Intervention: Gradient boosting machine
Number of subjects: 5159
Study 31062050 — intervention group
Group type: EXPERIMENTAL
Intervention: norMP in patients with mild ARDS
Number of subjects: 5159
Study 27818304 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth-program, TXT2BFiT (three-month intensive phase and six-month maintenance phase)
Number of subjects: 250
Study 27818304 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth-program, TXT2BFiT
Number of subjects: 250
Study 27818304 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 250
Study 25906706 — intervention group
Group type: EXPERIMENTAL
Intervention: NCH gel
Number of subjects: 216
Study 25906706 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 216
Study 24742116 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT)
Number of subjects: 164
Study 24742116 — intervention group
Group type: EXPERIMENTAL
Intervention: Group multimodal intervention (MMI)
Number of subjects: 164
Study 24742116 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 164
Study 22948406 — intervention group
Group type: EXPERIMENTAL
Intervention: TeleFamilies intervention with advanced practice nurse as care coordinator; details on dosage and duration not specified.
Number of subjects: 0
Study 20186843 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of plasma IP-10
Number of subjects: 265
Study 20186843 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of intrahepatic IP-10
Number of subjects: 265
Study 20186843 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma levels of IP-10
Number of subjects: 265
Study 20186843 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment plasma samples from NORDynamIC trial
Number of subjects: 265
Study 18268075 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (15 mg/day)
Number of subjects: 5269
Study 18268075 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone (8 mg/day)
Number of subjects: 5269
Study 18268075 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (for both interventions)
Number of subjects: 5269
Study 16200556 — intervention group
Group type: EXPERIMENTAL
Intervention: Home chemotherapy
Number of subjects: 23
Study 16200556 — intervention group
Group type: COMPARATOR
Intervention: Hospital chemotherapy
Number of subjects: 23
Study 15785179 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapies (angioplasty, stenting, endoluminal stent grafts)
Number of subjects: 0
Study 15785179 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent-supported carotid angioplasty with cerebral protection
Number of subjects: 0
Study 15785179 — intervention group
Group type: EXPERIMENTAL
Intervention: Less invasive techniques for abdominal aortic aneurysms using endoluminal stent grafts
Number of subjects: 0
Study 10743395 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching strategy by a public health nurse with leaflet and video
Number of subjects: 149
Study 10743395 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching strategy by a breast cancer survivor with slides and silicon breast models
Number of subjects: 149
Study 10743395 — intervention group
Group type: COMPARATOR
Intervention: Control strategy by a primary care nurse with leaflet and video based on Health Secretariat's guidelines
Number of subjects: 149
Study 9685782 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning laser ophthalmoscopy in children with glaucoma and myopia (group I)
Number of subjects: 29
Study 9685782 — intervention group
Group type: COMPARATOR
Intervention: Control group (group II)
Number of subjects: 29
Study 8497821 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate with a 750 ml spacer (group S)
Number of subjects: 50
Study 8497821 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate without a spacer (group MDI)
Number of subjects: 50
Study 8497821 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups at 2 mg/day of beclomethasone dipropionate
Number of subjects: 50
Study 3305379 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexapneumine
Number of subjects: 100
Study 3305379 — intervention group
Group type: COMPARATOR
Intervention: Clistine
Number of subjects: 100
Study 3305379 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexapneumine and Clistine
Number of subjects: 100
Study 29147731 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypokinesia (60 min of wearing a stiff neck collar)
Number of subjects: 20
Study 29147731 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypokinesia (120 min of wearing a stiff neck collar)
Number of subjects: 20
Study 29147731 — intervention group
Group type: COMPARATOR
Intervention: Cervical hyperkinesia (20 min of extensive active neck movement)
Number of subjects: 20
Study 28318164 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric tube interposition by touching laryngeal prominence
Number of subjects: 66
Study 28318164 — intervention group
Group type: COMPARATOR
Intervention: Regular gastric tube interposition
Number of subjects: 66
Study 25047825 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysate sodium 135 mM
Number of subjects: 96
Study 25047825 — intervention group
Group type: COMPARATOR
Intervention: Dialysate sodium 140 mM
Number of subjects: 96
Study 22537558 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (ESCAPE: Evaluation of Stepped Care for Chronic Pain)
Number of subjects: 26
Study 20810877 — intervention group
Group type: EXPERIMENTAL
Intervention: Aphasia treatment targeting anomia (30 hours of treatment)
Number of subjects: 26
Study 20810877 — intervention group
Group type: EXPERIMENTAL
Intervention: Aphasia treatment targeting anomia
Number of subjects: 26
Study 18438689 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical morphine (0.1%, 0.2%, 0.4%)
Number of subjects: 16
Study 18438689 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical buprenorphine (0.01%, 0.02%, 0.1%)
Number of subjects: 16
Study 18438689 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 16
Study 18438689 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 16
Study 15958804 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib (1.3 mg/m² IV on days 1, 4, 8, and 11 for eight three-week cycles, then days 1, 8, 15, and 22 for three five-week cycles)
Number of subjects: 669
Study 15958804 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone (40 mg orally on days 1-4, 9-12, and 17-20 for four five-week cycles, then days 1-4 for five four-week cycles)
Number of subjects: 669
Study 12724125 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement splint (MAS)
Number of subjects: 10
Study 10643226 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with insulin and metformin
Number of subjects: 0
Study 10643226 — intervention group
Group type: COMPARATOR
Intervention: Insulin alone
Number of subjects: 0
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine and steroid immunosuppressive therapy (CSA regimen)
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose cyclosporine (4 mg/kg/day), steroid therapy, and 21-day course of 500 mg/day antilymphocyte globulin (ALG 1 regimen)
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose cyclosporine (6 mg/kg/day), steroid therapy, and 14-day course of 1,000 mg/day antilymphocyte globulin (ALG 2 regimen)
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose cyclosporine (6 mg/kg/day), steroid therapy, and 14-day course of 1,000 mg/day antilymphocyte globulin followed by 2 mg/kg/day mizoribine (ALG 3 regimen)
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 and steroid therapy (FK506 regimen)
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine and steroid therapy
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: ALG 1 regimen
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: ALG 2 regimen
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: ALG 3 regimen
Number of subjects: 276
Study 8896734 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 regimen
Number of subjects: 276
Study 8287666 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodialysis
Number of subjects: 35
Study 8287666 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ambulatory peritoneal dialysis
Number of subjects: 35
Study 8287666 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic renal failure (not receiving maintenance dialysis)
Number of subjects: 35
Study 8287666 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (healthy)
Number of subjects: 35
Study 3477989 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal hysterectomy
Number of subjects: 212
Study 3477989 — intervention group
Group type: EXPERIMENTAL
Intervention: Supravaginal uterine amputation
Number of subjects: 212
Study 3477989 — intervention group
Group type: COMPARATOR
Intervention: Comparison at 3 years
Number of subjects: 212
Study 29125975 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental monitoring
Number of subjects: 999
Study 29125975 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive family relations
Number of subjects: 999
Study 29125975 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial peer affiliation
Number of subjects: 999
Study 29125975 — intervention group
Group type: EXPERIMENTAL
Intervention: Deviant peer affiliation
Number of subjects: 999
Study 29125975 — intervention group
Group type: EXPERIMENTAL
Intervention: Friendship environment
Number of subjects: 999
Study 27523980 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted biopsies (biopsies collected from locations of suspected neoplasia), n = 124
Number of subjects: 246
Study 27523980 — intervention group
Group type: COMPARATOR
Intervention: Random biopsies (4 random biopsies collected every 10 cm in addition to targeted biopsies), n = 122
Number of subjects: 246
Study 24553695 — intervention group
Group type: EXPERIMENTAL
Intervention: Echium oil (EO) 17 g/d (2 g SDA)
Number of subjects: 80
Study 24553695 — intervention group
Group type: COMPARATOR
Intervention: Fish oil (FO) 17 g/d (1.9 g EPA)
Number of subjects: 80
Study 23249501 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive rifampicin (600-900 mg/day; orally or intravenously)
Number of subjects: 940
Study 23249501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 940
Study 20456738 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin 500 mg daily
Number of subjects: 65
Study 20456738 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice daily
Number of subjects: 65
Study 18215589 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 2000
Study 18215589 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stents (DESs)
Number of subjects: 2000
Study 16199841 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy (40 sessions)
Number of subjects: 156
Study 16199841 — intervention group
Group type: COMPARATOR
Intervention: Community-delivered psychodynamic therapy
Number of subjects: 156
Study 16199841 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive psychotherapy
Number of subjects: 156
Study 14520722 — intervention group
Group type: EXPERIMENTAL
Intervention: 25‐OH‐vitamin D (cholecalciferol) 15 microg (600 IU) once daily
Number of subjects: 17
Study 14520722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 11220352 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (half a pill before lunch and half a pill before dinner)
Number of subjects: 30
Study 11220352 — intervention group
Group type: COMPARATOR
Intervention: Placebo (50 mg of starch)
Number of subjects: 30
Study 8889120 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal encouragement
Number of subjects: 20
Study 8889120 — intervention group
Group type: COMPARATOR
Intervention: No verbal encouragement (Control)
Number of subjects: 20
Study 1856305 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel 2%
Number of subjects: 10
Study 1856305 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride gel 1.25%
Number of subjects: 10
Study 1856305 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannous fluoride gel 4%
Number of subjects: 10
Study 1856305 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 10
Study 7174305 — intervention group
Group type: EXPERIMENTAL
Intervention: Pizotifen 0.5 mg t.d.s.
Number of subjects: 17
Study 7174305 — intervention group
Group type: EXPERIMENTAL
Intervention: Pizotifen 1.5 mg nocte
Number of subjects: 17
Study 31214178 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil and MUC1/polyICLC vaccine
Number of subjects: 0
Study 28174906 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg praziquantel
Number of subjects: 217
Study 28174906 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg praziquantel
Number of subjects: 217
Study 28174906 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg praziquantel
Number of subjects: 217
Study 28174906 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 × 25 mg/kg praziquantel
Number of subjects: 217
Study 28174906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 26864131 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg once daily
Number of subjects: 47